What was Bio Preventive Medicine Corp.’s price range in the past 12 months?
Bio Preventive Medicine Corp. lowest stock price was TWD 16.50 and its highest was TWD 46.00 in the past 12 months.
What is Bio Preventive Medicine Corp.’s market cap?
Bio Preventive Medicine Corp.’s market cap is TWD 998.86M.
When is Bio Preventive Medicine Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Bio Preventive Medicine Corp. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bio Preventive Medicine Corp. pay dividends?
Bio Preventive Medicine Corp. does not currently pay dividends.
What is Bio Preventive Medicine Corp.’s EPS estimate?
Bio Preventive Medicine Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio Preventive Medicine Corp. have?
Bio Preventive Medicine Corp. has 49,448,500 shares outstanding.
Which hedge fund is a major shareholder of Bio Preventive Medicine Corp.?
Currently, no hedge funds are holding shares in TW:6810
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio Preventive Medicine Corp.
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.